Abstract
We examined the effect of a protein synthesis inhibitor, cycloheximide (CHX) on the adenomatous polyposis coli (APC) mRNA levels in HCT-116 colon cancer cell line. The HCT-116 cells were treated with different concentrations of CHX for 15 h. APC, p53 and beta-actin mRNA levels were determined by Northern blotting. Results showed that APC and beta-actin mRNA levels were significantly increased in a dose-dependent manner after CHX treatment. The p53 mRNA levels were moderately increased. The increase in APC mRNA levels after CHX treatment was due to increase in its stability instead of transcription. These results provide a model for CHX-induced APC mRNA stabilization and its implication in cell cycle arrest and cell survival studies.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenomatous Polyposis Coli Protein
-
Colonic Neoplasms / genetics
-
Colonic Neoplasms / metabolism*
-
Cycloheximide / pharmacology*
-
Cytoskeletal Proteins / antagonists & inhibitors
-
Cytoskeletal Proteins / biosynthesis*
-
Cytoskeletal Proteins / genetics
-
Dose-Response Relationship, Drug
-
Gene Expression Regulation, Neoplastic
-
Genes, APC / drug effects
-
Humans
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm Proteins / biosynthesis*
-
Neoplasm Proteins / genetics
-
Protein Synthesis Inhibitors / pharmacology*
-
RNA, Messenger / antagonists & inhibitors
-
RNA, Messenger / metabolism*
-
Tumor Cells, Cultured
Substances
-
Adenomatous Polyposis Coli Protein
-
Cytoskeletal Proteins
-
Neoplasm Proteins
-
Protein Synthesis Inhibitors
-
RNA, Messenger
-
Cycloheximide